Institutional investors hold a majority ownership of ABBV through the 71.45% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended September 2017, these large investors purchased a net $18.0 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 11.8 Million shares of AbbVie
CAPITAL RESEARCH & MANAGEMENT CO... Bought 10.7 Million shares of AbbVie
JENNISON ASSOCIATES LLC Bought 6.1 Million shares of AbbVie